Veterinary Medicine Information website

EURICAN DAP-LR LIOFILIZADO Y SUSPENSIÓN PARA SUSPENSIÓN INYECTABLE PARA PERROS

Not authorised
  • Canine parvovirus, strain CAG2, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
  • Rabies virus, strain G52, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
Download as PDF

Product identification

Medicine name:
EURICAN DAP-LR LIOFILIZADO Y SUSPENSIÓN PARA SUSPENSIÓN INYECTABLE PARA PERROS
Active substance:
  • Canine parvovirus, strain CAG2, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
  • Rabies virus, strain G52, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
Target species:
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain CAG2, Live
    4.90
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain DK13, Live
    2.50
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain BA5, Live
    4.00
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Rabies virus, strain G52, Inactivated
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    80.00
    percentage protection
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
    80.00
    percentage protection
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Espana S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 3126 ESP
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023
Download